Email this article Bleeding rate reduction in children with hemophilia A and inhibitors treated with emicizumab in the real-world clinical setting - PDF (Russian)
Copyright (c) 2022 Zharkov P.А., Voronin K.A., Andreeva T.A., Asekretova T.V., Belkina Y.E., Demikhov V.G., Zinina E.E., Kolyasina T.A., Lebedev V.V., Markova I.V., Osmulskaya N.S., Petrov V.Y., Skobin V.B., Spichak O.V., Shelekhova T.V., Sherstnev D.G.
This work is licensed under a Creative Commons Attribution 4.0 International License.